Search - tctmd.com

Displaying 101 - 120 of 668

Sort: Relevancy | Date

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

Yael L. Maxwell

January 25, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’

L.A. McKeown

January 08, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

AHA Updates Its Scientific Statement on CIED Infections

Todd Neale

December 11, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

Presentation AHA 2023

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

Presenter: Alexander C. Fanaroff

November 13, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

Advertisement

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

TAVI, SAVR Almost Equally Performed in California Patients Under 60

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

AHA Marks 100 Years: ‘We Truly Stand on the Shoulders of Giants’

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

AHA Selects 2023’s Leading Cardiovascular Research

Top Coronary Artery Disease News of 2023

AHA Updates Its Scientific Statement on CIED Infections

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

JACC Statement Focuses on PAD Disparities, Gaps in Care

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Two Randomized Controlled Trials of Nudges to Encourage Referrals to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients: The SUPER LIPID Program

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Approves Paradise Renal Denervation System: What Comes Next?

What’s Going to Be Hot at AHA 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content